These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23586811)

  • 1. Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation.
    Katafuchi T
    Biosci Rep; 2013 May; 33(3):. PubMed ID: 23586811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP.
    Dickey DM; Otto NM; Potter LR
    J Biol Chem; 2017 Jun; 292(24):10220-10229. PubMed ID: 28450398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-B.
    Robinson JW; Dickey DM; Miura K; Michigami T; Ozono K; Potter LR
    Bone; 2013 Oct; 56(2):375-82. PubMed ID: 23827346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Male mice with elevated C-type natriuretic peptide-dependent guanylyl cyclase-B activity have increased osteoblasts, bone mass and bone strength.
    Robinson JW; Blixt NC; Norton A; Mansky KC; Ye Z; Aparicio C; Wagner BM; Benton AM; Warren GL; Khosla S; Gaddy D; Suva LJ; Potter LR
    Bone; 2020 Jun; 135():115320. PubMed ID: 32179168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of NPR-B/GC-B by protein kinase c and calcium.
    Abbey-Hosch SE; Smirnov D; Potter LR
    Biochem Pharmacol; 2005 Sep; 70(5):686-94. PubMed ID: 16005434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The indolocarbazole, Gö6976, inhibits guanylyl cyclase-A and -B.
    Robinson JW; Lou X; Potter LR
    Br J Pharmacol; 2011 Sep; 164(2b):499-506. PubMed ID: 21366551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
    Crook RB; Chang AT
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization.
    Potter LR
    Biochemistry; 1998 Feb; 37(8):2422-9. PubMed ID: 9485390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity and expression of soluble and particulate guanylate cyclases in myometrium from nonpregnant and pregnant women: down-regulation of soluble guanylate cyclase at term.
    Telfer JF; Itoh H; Thomson AJ; Norman JE; Nakao K; Campa JS; Poston L; Tribe RM; Magness RR
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5934-43. PubMed ID: 11739467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-type natriuretic peptide regulation of guanosine-3',5'-cyclic monophosphate production in human endothelial cells.
    Rautureau Y; Gowers I; Wheeler-Jones CP; Baxter GF
    Auton Autacoid Pharmacol; 2010 Jul; 30(3):185-92. PubMed ID: 20085572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.
    Potter LR
    Pharmacol Ther; 2011 Apr; 130(1):71-82. PubMed ID: 21185863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of C-type natriuretic peptide on rat astrocytes: regional differences and characterization of receptors.
    Deschepper CF; Picard S
    J Neurochem; 1994 May; 62(5):1974-82. PubMed ID: 7908948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expression of natriuretic peptide receptors: effects of HS-142-1, a non-peptide ANP antagonist.
    Ohyama Y; Miyamoto K; Morishita Y; Matsuda Y; Saito Y; Minamino N; Kangawa K; Matsuo H
    Biochem Biophys Res Commun; 1992 Nov; 189(1):336-42. PubMed ID: 1360206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of the major phosphorylation sites of the B-type natriuretic peptide receptor.
    Potter LR; Hunter T
    J Biol Chem; 1998 Jun; 273(25):15533-9. PubMed ID: 9624142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
    Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
    Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-type natriuretic peptide and the guanylyl cyclase receptors in the rat ovary are modulated by the estrous cycle.
    Jankowski M; Reis AM; Mukaddam-Daher S; Dam TV; Farookhi R; Gutkowska J
    Biol Reprod; 1997 Jan; 56(1):59-66. PubMed ID: 9002633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B.
    Abbey SE; Potter LR
    Endocrinology; 2003 Jan; 144(1):240-6. PubMed ID: 12488350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization.
    Simon A; Harrington EO; Liu GX; Koren G; Choudhary G
    Am J Physiol Lung Cell Mol Physiol; 2009 Feb; 296(2):L248-56. PubMed ID: 19036874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional screen provides evidence for a conserved, regulatory, juxtamembrane phosphorylation site in guanylyl cyclase a and B.
    Yoder AR; Robinson JW; Dickey DM; Andersland J; Rose BA; Stone MD; Griffin TJ; Potter LR
    PLoS One; 2012; 7(5):e36747. PubMed ID: 22590601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects of Leydig cell function.
    Middendorff R; Müller D; Paust HJ; Holstein AF; Davidoff MS
    Adv Exp Med Biol; 1997; 424():125-38. PubMed ID: 9361777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.